{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,21]],"date-time":"2026-11-21T02:31:05Z","timestamp":1795228265311,"version":"4.10.3"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>This study aimed to validate the clinical utility of visual and software-based quantitative AV-45 PET analyses and compare treatment effects between lecanemab and deep cervical lymphatic\u2013venous anastomosis (dcLVA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This retrospective cohort study included Alzheimer\u2019s disease patients who received 6-month lecanemab therapy or dcLVA surgery between July 2024 and 2025. AV-45 PET was performed 1 week before and 6 months after treatment. Standardized uptake value ratios (SUVRs) and centiloids (CLs) were obtained using visual and quantitative analyses. Agreement was assessed using Cohen\u2019s\n                      <jats:italic toggle=\"yes\">\u03ba<\/jats:italic>\n                      and intraclass correlation coefficients (ICC). Receiver operating characteristic (ROC) analysis evaluated diagnostic performance. Logistic regression used Informant Questionnaire on Cognitive Decline in the Elderly score greater than or equal to 3.3 as the outcome.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Baseline characteristics were comparable between groups (all\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &gt; 0.05). Visual assessment showed good agreement with centiloid quantification (\n                      <jats:italic toggle=\"yes\">\u03ba<\/jats:italic>\n                      = 0.72, ICC = 0.663). ROC analysis identified \u0394CL as the optimal marker (area under the curve = 0.764,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.026), with a cutoff of \u221211.5%. \u0394CL \u2265 \u221211.5% independently predicted cognitive decline in the lecanemab group (odds ratio = 10.281, 95% confidence interval = 1.289\u201382.005;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.028). Cognitive decline was less frequent in the lecanemab group (23.5 vs. 81.8%;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001). \u0394CL differed significantly between groups (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.006), whereas \u0394SUVR did not.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Visual and centiloid-based AV-45 PET analyses show good concordance for monitoring Alzheimer\u2019s disease treatment response. \u0394CL is a robust marker of lecanemab efficacy, which is superior to dcLVA in reducing amyloid-\u03b2 burden and delaying cognitive decline.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/mnm.0000000000002184","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T08:00:44Z","timestamp":1779868844000},"page":"1188-1195","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Quantitative AV-45 PET imaging for assessing treatment response to lecanemab and deep cervical lymphatic\u2013venous anastomosis in Alzheimer\u2019s disease"],"prefix":"10.1097","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-8094-0952","authenticated-orcid":false,"given":"Luqiang","family":"Jin","sequence":"first","affiliation":[{"name":"Cancer Center, Department of Nuclear Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Wang","sequence":"additional","affiliation":[{"name":"Cancer Center, Department of Nuclear Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahuan","family":"Song","sequence":"additional","affiliation":[{"name":"Cancer Center, Department of Nuclear Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Hou","sequence":"additional","affiliation":[{"name":"Cancer Center, Department of Radiology, Zhejiang Provincial People\u2019s Hospital (Affiliated People\u2019s Hospital), Hangzhou Medical College, Hangzhou, Zhejiang"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueqian","family":"Bi","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Heze Rongjun Youfu Hospital, Heze, Shandong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuehua","family":"Wen","sequence":"additional","affiliation":[{"name":"Cancer Center, Department of Radiology, Zhejiang Provincial People\u2019s Hospital (Affiliated People\u2019s Hospital), Hangzhou Medical College, Hangzhou, Zhejiang"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Wang","sequence":"additional","affiliation":[{"name":"Center for Rehabilitation Medicine, Department of Neurology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangyuan","family":"Lai","sequence":"additional","affiliation":[{"name":"Center for Plastic & Reconstructive Surgery, Department of Hand & Reconstructive Surgery, Zhejiang Provincial People\u2019s Hospital (Affiliated People\u2019s Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4642-4426","authenticated-orcid":false,"given":"Aiping","family":"Cheng","sequence":"additional","affiliation":[{"name":"Cancer Center, Department of Nuclear Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,9,8]]},"reference":[{"key":"R1-20260909","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41392-024-01911-3","article-title":"Recent advances in Alzheimer\u2019s disease: mechanisms, clinical trials and new drug development strategies.","volume":"9","author":"Zhang","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"R2-20260909","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","article-title":"Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019.","volume":"7","year":"2022","journal-title":"Lancet Public Health"},{"key":"R3-20260909","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer\u2019s disease.","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet"},{"key":"R4-20260909","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1016\/S0140-6736(24)01883-X","article-title":"Passive anti-amyloid \u03b2 immunotherapy in Alzheimer\u2019s disease\u2014opportunities and challenges.","volume":"404","author":"Heneka","year":"2024","journal-title":"Lancet"},{"key":"R5-20260909","doi-asserted-by":"crossref","first-page":"102620","DOI":"10.1016\/j.arr.2024.102620","article-title":"Monoclonal therapy with lecanemab in the treatment of mild Alzheimer\u2019s disease: a systematic review and meta-analysis.","volume":"104","author":"Arroyo-Pacheco","year":"2025","journal-title":"Ageing Res Rev"},{"key":"R6-20260909","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer\u2019s disease.","volume":"388","author":"van Dyck","year":"2023","journal-title":"N Engl J Med"},{"key":"R7-20260909","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1016\/S0140-6736(22)02480-1","article-title":"Lecanemab for Alzheimer\u2019s disease: tempering hype and hope.","volume":"400","year":"2022","journal-title":"Lancet"},{"key":"R8-20260909","doi-asserted-by":"crossref","first-page":"4260","DOI":"10.1016\/j.cell.2023.08.021","article-title":"Alzheimer\u2019s disease: from immunotherapy to immunoprevention.","volume":"186","author":"Jucker","year":"2023","journal-title":"Cell"},{"key":"R9-20260909","doi-asserted-by":"crossref","first-page":"9002","DOI":"10.1097\/JS9.0000000000004561","article-title":"Deep cervical lymphatic-venous anastomosis in dementia: a clinical and mechanistic evaluation.","volume":"112","author":"Tang","year":"2025","journal-title":"Int J Surg"},{"key":"R10-20260909","doi-asserted-by":"crossref","first-page":"e101641","DOI":"10.1136\/gpsych-2024-101641","article-title":"Promising outcomes 5 weeks after a surgical cervical shunting procedure to unclog cerebral lymphatic systems in a patient with Alzheimer\u2019s disease.","volume":"37","author":"Li","year":"2024","journal-title":"Gen. Psychiatry"},{"key":"R11-20260909","doi-asserted-by":"crossref","first-page":"25424823251384244","DOI":"10.1177\/25424823251384244","article-title":"A surgical therapy for Alzheimer\u2019s disease with lymphaticovenular anastomosis.","volume":"9","author":"Ma","year":"2025","journal-title":"J Alzheimers Dis Rep"},{"key":"R12-20260909","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/s41586-018-0368-8","article-title":"Functional aspects of meningeal lymphatics in ageing and Alzheimer\u2019s disease.","volume":"560","author":"Da Mesquita","year":"2018","journal-title":"Nature"},{"key":"R13-20260909","first-page":"899","article-title":"Surgical advances in the treatment of Alzheimer\u2019s disease: a comprehensive review.","volume":"107","author":"Xie","year":"2025","journal-title":"J Alzheimers Dis"},{"key":"R14-20260909","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nrneurol.2018.9","article-title":"Imaging tau and amyloid-\u03b2 proteinopathies in Alzheimer disease and other conditions.","volume":"14","author":"Villemagne","year":"2018","journal-title":"Nat Rev Neurol"},{"key":"R15-20260909","doi-asserted-by":"crossref","first-page":"585","DOI":"10.3233\/JAD-221251","article-title":"18F-AV45 PET and MRI reveal the influencing factors of Alzheimer\u2019s disease biomarkers in subjective cognitive decline population.","volume":"93","author":"Zhao","year":"2023","journal-title":"J Alzheimers Dis"},{"key":"R16-20260909","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.2967\/jnumed.119.240325","article-title":"Amyloid PET in dementia syndromes: a Chinese multicenter study.","volume":"61","author":"Shi","year":"2020","journal-title":"J Nucl Med"},{"key":"R17-20260909","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease.","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement"},{"key":"R18-20260909","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13195-021-00813-8","article-title":"A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer\u2019s disease with lecanemab, an anti-A\u03b2 protofibril antibody.","volume":"13","author":"Swanson","year":"2021","journal-title":"Alzheimers Res Ther"},{"key":"R19-20260909","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/s41573-022-00391-w","article-title":"The amyloid hypothesis in Alzheimer disease: new insights from new therapeutics.","volume":"21","author":"Karran","year":"2022","journal-title":"Nat Rev Drug Discovery"},{"key":"R20-20260909","first-page":"CD011333","article-title":"Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the early detection of dementia across a variety of healthcare settings.","volume":"7","author":"Burton","year":"2021","journal-title":"Cochrane Database Syst. Rev"},{"key":"R21-20260909","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","article-title":"Alzheimer disease: an update on pathobiology and treatment strategies.","volume":"179","author":"Long","year":"2019","journal-title":"Cell"},{"key":"R22-20260909","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/brain\/awaa373","article-title":"CSF tau microtubule binding region identifies tau tangle and clinical stages of Alzheimer\u2019s disease.","volume":"144","author":"Horie","year":"2021","journal-title":"Brain"},{"key":"R23-20260909","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.2174\/0929867331666230731123226","article-title":"Simple synthesis of [18F] AV-45 and its clinical application in the diagnosis of Alzheimer\u2019s disease.","volume":"31","author":"Zhang","year":"2024","journal-title":"Curr Med Chem"},{"key":"R24-20260909","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1056\/NEJMoa2305032","article-title":"Trial of solanezumab in preclinical Alzheimer\u2019s disease.","volume":"389","author":"Sperling","year":"2023","journal-title":"N Engl J Med"},{"key":"R25-20260909","doi-asserted-by":"crossref","first-page":"5102","DOI":"10.1002\/alz.13883","article-title":"Stress testing the Centiloid: precision and variability of PET quantification of amyloid pathology.","volume":"20","author":"Shekari","year":"2024","journal-title":"Alzheimers Dement"},{"key":"R26-20260909","doi-asserted-by":"crossref","first-page":"4211","DOI":"10.1097\/JS9.0000000000002490","article-title":"Deep cervical lymphovenous anastomosis (LVA) for Alzheimer\u2019s disease: microsurgical procedure in a prospective cohort study.","volume":"111","author":"Chen","year":"2025","journal-title":"Int. J. Surg"},{"key":"R27-20260909","doi-asserted-by":"crossref","first-page":"e71038","DOI":"10.1002\/alz.71038","article-title":"Deep cervical lymphaticovenous anastomosis for Alzheimer\u2019s disease: a narrative review.","volume":"21","author":"Chen","year":"2025","journal-title":"Alzheimers Dement"},{"key":"R28-20260909","doi-asserted-by":"crossref","first-page":"e102062","DOI":"10.1136\/gpsych-2025-102062","article-title":"Lymphatic-venous anastomosis surgery for Alzheimer\u2019s disease.","volume":"38","author":"Wang","year":"2025","journal-title":"Gen. Psychiatry"}],"container-title":["Nuclear Medicine Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MNM.0000000000002184","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T10:19:23Z","timestamp":1788949163000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MNM.0000000000002184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,8]]},"references-count":28,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/mnm.0000000000002184","relation":{},"ISSN":["0143-3636","1473-5628"],"issn-type":[{"value":"0143-3636","type":"print"},{"value":"1473-5628","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,8]]},"assertion":[{"value":"2026-03-01","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-12","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}